Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19

被引：23
|
作者：
Razonable, Raymund R. [1 ]
Ganesh, Ravindra [2 ]
Bierle, Dennis M. [2 ]
机构：
[1] Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN USA
来源：
MAYO CLINIC PROCEEDINGS | 2022年 / 97卷 / 01期
关键词：
D O I：
10.1016/j.mayocp.2021.11.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 30
页数：5
相关论文
共 50 条
  • [1] Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19
    Malani, Preeti N.
    Golub, Robert M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 644 - 645
  • [2] Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19
    Knox, Hannah B.
    Dykes, Lisa A.
    Scott, Lancer A.
    Presley, Bradley C.
    Lambert, Lara C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 985 - 993
  • [3] Monoclonal Antibody and Antiviral Therapy for Mild-to-Moderate COVID-19 in Pediatric Patients
    Vora, Surabhi B. B.
    Englund, Janet A. A.
    Trehan, Indi
    Waghmare, Alpana
    Kong, Ada
    Adler, Amanda
    Zerr, Danielle M. M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (01) : 32 - 34
  • [4] Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents
    Wolf, Joshua
    Abzug, Mark J.
    Anosike, Brenda, I
    Vora, Surabhi B.
    Waghmare, Alpana
    Sue, Paul K.
    Olivero, Rosemary M.
    Oliveira, Carlos R.
    James, Scott H.
    Morton, Theodore H.
    Maron, Gabriela M.
    Young, Jennifer L.
    Orscheln, Rachel C.
    Schwenk, Hayden T.
    Bio, Laura L.
    Willis, Zachary, I
    Lloyd, Elizabeth C.
    Hersh, Adam L.
    Huskins, Charles W.
    Soma, Vijaya L.
    Ratner, Adam J.
    Hayes, Molly
    Downes, Kevin
    Chiotos, Kathleen
    Grapentine, Steven P.
    Wattier, Rachel L.
    Lamb, Gabriella S.
    Zachariah, Philip
    Nakamura, Mari M.
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (05) : 177 - 185
  • [5] Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19
    Lim, C.
    Eiting, E.
    O'Neill, A.
    Farraj, R.
    Koshy, S.
    Simms, C.
    Devlin, A.
    Nunez, J.
    Calderon, Y.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2021, 78 (02) : S15 - S15
  • [6] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [7] Treatment of COVID-19 Patients with mild or moderate Disease
    Lichert, Frank
    [J]. PNEUMOLOGIE, 2021, 75 (03): : 174 - 174
  • [8] MONOCLONAL ANTIBODIES RECEIVE EUA TO TREAT MILD TO MODERATE COVID-19
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 2021, 121 (02) : 26 - 26
  • [9] Role of monoclonal antibody drugs in the treatment of COVID-19
    Ucciferri, Claudio
    Vecchiet, Jacopo
    Falasca, Katia
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (19) : 4280 - 4285
  • [10] Role of monoclonal antibody drugs in the treatment of COVID-19
    Claudio Ucciferri
    Jacopo Vecchiet
    Katia Falasca
    [J]. World Journal of Clinical Cases, 2020, (19) : 4280 - 4285
12345